Searchable abstracts of presentations at key conferences in endocrinology

ea0003p36 | Clinical Case Reports | BES2002

Efficacy and safety of high dose testosterone therapy in partial androgen insensitivity

Bandyopadhyay S , Watson W , Park C , Abraham P , Philip S , Acharya S , Bevan J

Efficacy and Safety of High Dose Testosterone Therapy in Partial Androgen InsensitivityS. Bandyopadhyay, W.A.Watson, C. M.Park, P. Abraham, S. Philip, S. Acharya , J.S. Bevan. Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN.INTRODUCTION: There have been few reports of the efficacy and safety of high dose androgen therapy in men with partial androgen insensitivity (PAI). We report on the responses of a p...

ea0011p115 | Clinical case reports | ECE2006

A long-standing lump in the neck proving troublesome for the surgeons

Bandyopadhyay S , Vora JP

Case report: A 68 year old lady was admitted for an elective partial hepatectomy for a solitary metastasis in the liver. Two years ago she had an uneventful colectomy for a colorectal cancer. During induction for her operation she was noted to be hypertensive {blood pressure (BP) 200/120 mm of mercury (Hg)}, though had not been observed to be so previously, and hence her partial hepatectomy had to be abandoned. She was commenced on atenolol and operation rescheduled. The secon...

ea0011p122 | Clinical case reports | ECE2006

Is the continuation of lithium treatment safe during peri-operative periods?

Tan A , Bandyopadhyay S , Vora JP

Case report: A 40-year old male with a background history of autism, severe learning difficulties and childhood Hirschsprung’s disease had been on long-term lithium carbonate therapy, without any history of polyuria or polydipsia. During admission he underwent a subtotal colectomy for malignant colonic polyps. Pre-operative serum urea and electrolytes, glucose and lithium levels were normal. Pre-operative fluid balance was normal. The post-operative period was turbulent; ...

ea0070ep221 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Association of CAPN10, FTO, PPAR, MTHFR gene polymorphisms and obesity with type 2 diabetes mellitus: A study on the bengalee hindu caste population of west bengal, india

Sarkar Pranabesh , Chatterjee Diptendu , Bandyopadhyay Arup Ratan

Background: Type 2 diabetes mellitus (DM) is probably one of the non-communicable diseases with raised levels of glucose in the blood due to insulin efficacy. The aetiology of disease combines both genetic and lifestyle or environmental factors. (GWAS) studies have been identified CAPN10 (SNP-19), FTO (rs-9939609), MTHFR (rs1801133) and PPARG (rs1801282) genetic polymorphism with susceptibility to T2DM. The susceptibility will increase by independent risk of genetic polymorphi...

ea0011p100 | Clinical case reports | ECE2006

Isolated secondary hypothyroidism in identical twins

Weston PJ , Annamalai AK , Bandyopadhyay S

Background: Isolated secondary hypothyroidism is rare. In the majority of cases the causes are genetic (gene mutations) or structural (mass effect or infiltration). Structural causes are usually associated with simultaneous deficiencies of other adenohypophyseal hormones. We present an identical twin with isolated secondary hypothyroidism.Case report: 1st Twin – 26-year-old obese lady, of Afro-carribean origin, presented with tiredness, weigh...

ea0011p212 | Comparative endocrinology | ECE2006

Dynamic macroprolactin and adjusted prolactin responses in hyperprolactinaemic patients

Bandyopadhyay S , Diver MJ , Vora JP

Background: Prolactin is found in serum in different molecular forms, differing in molecular size. Macroprolactin is a complex of prolactin with immunoglobulin and has limited biological activity due to failure to cross capillary wall because of its high molecular weight complex.Objective: To assess the response of the inactive macroprolactin and the biologically active monomeric prolactin, in patients with hyperprolactinaemia, during TRH and metoclopram...

ea0034p389 | Thyroid | SFEBES2014

Radioiodine therapy for thyrotoxicosis over a 2-year period: an audit

Clark Jennifer , Rao Ranganatha , Bandyopadhyay Prabir , De Parijat

Aims: To look at the demographics, biochemistry, treatments used, clinical characteristics associated with radioiodine (RI) treatment (including those with relapse) for thyrotoxicosis in our Endocrine clinic.Methods: Electronic records of all thyrotoxic patients between 2010 and 2012.Results: 144 patients, mean age 56 years (114 females)–106 Graves, 24 toxic adenoma (TA) and 14 multi nodular goitre (MNG). TPO antibody was posi...

ea0003p40 | Clinical Case Reports | BES2002

Differentiated thyroid carcinoma with large bony metastases - what is the best approach?

Watson W , Park C , Abraham P , Bandyopadhyay S , Philip S , Acharya S , Samuel L , Bevan J

The high survival rate for patients with differentiated thyroid carcinoma (DTC) declines markedly in those with bony metastases. We compare the management of two patients with large dominant pelvic metastases.Case 1 63 year old man with R hip pain. Investigation revealed a 10cm lesion in the R hemi pelvis and subsequent imaging and biopsy revealed a 9th rib lesion and metastatic follicular DTC. He underwent 131 I ablation of the normal thyroi...

ea0003p48 | Clinical Case Reports | BES2002

Multidisciplinary management of Cushing's syndrome due to a malignant thymic carcinoid tumour

Park C , Watson W , Abraham P , Acharya S , Bandyopadhyay S , Philip S , Samuel L , Nicolson M , Bevan J

Thymic carcinoma is a rare but aggressive cause of ectopic ACTH secretion, with fewer than 100 reported cases.Hypokalaemic alkalosis was found in a 38 year old woman who presented with a 2-week history of leg swelling, fatigue and dyspnoea. She was not obviously Cushingoid.ACTH-dependent Cushing's Syndrome was confirmed biochemically: urinary free cortisol (UFC) >8500nmol/day and serum cortisol 4060nmol/l, (no suppression on 8...

ea0003p148 | Endocrine Tumours and Neoplasia | BES2002

Primary medical management of macroprolactinomas with cabergoline(CAB)

Philip S , Booth A , Abraham P , Kumaravel M , Watson W , Park C , Bandyopadhyay S , Acharya S , Bevan J

Objective: To establish the efficacy of CAB as primary and exclusive therapy in the management of macroprolactinomasMethod: Retrospective case note review of all patients with macroprolactinomas treated with CAB since the drug received a UK licence in 1994. Patients: Sixteen patients (8males, 8 females) with mean age at presentation of 42.3yrs (range 22-72 years) were treated with initial CAB doses ranging from 0.5-1mg/week (median 1mg/week). Results: T...